Allstate (NYSE:ALL) Price Target Raised to $229.00

Allstate (NYSE:ALL) had its price target raised by Wells Fargo & Company from $227.00 to $229.00 in a report released on Thursday,Benzinga reports. They currently have an equal weight rating on the insurance provider’s stock.

Several other analysts have also issued reports on ALL. Cantor Fitzgerald reissued a “neutral” rating and set a $220.00 price target on shares of Allstate in a report on Thursday, February 5th. Raymond James Financial reissued a “strong-buy” rating and set a $260.00 price target on shares of Allstate in a report on Tuesday, March 3rd. Morgan Stanley reissued an “equal weight” rating and set a $215.00 price target (down from $245.00) on shares of Allstate in a report on Tuesday, December 16th. Citigroup boosted their price target on Allstate from $216.00 to $221.00 and gave the company a “neutral” rating in a report on Tuesday, February 10th. Finally, Evercore set a $225.00 price target on Allstate in a report on Wednesday, January 7th. Three analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $238.65.

Allstate Stock Performance

Shares of ALL opened at $211.29 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.37 and a quick ratio of 0.37. Allstate has a one year low of $184.62 and a one year high of $216.75. The firm has a market capitalization of $54.84 billion, a P/E ratio of 5.53, a PEG ratio of 0.42 and a beta of 0.22. The business has a fifty day moving average of $207.74 and a 200 day moving average of $205.38.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.72 by $5.59. Allstate had a return on equity of 39.20% and a net margin of 15.19%.The business had revenue of $17.35 billion during the quarter, compared to analyst estimates of $17.23 billion. During the same quarter in the previous year, the company posted $7.67 earnings per share. Allstate’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Allstate will post 18.74 EPS for the current year.

Allstate Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 2.0%. This is a positive change from Allstate’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend was Monday, March 2nd. Allstate’s dividend payout ratio is currently 11.31%.

Hedge Funds Weigh In On Allstate

A number of hedge funds have recently made changes to their positions in ALL. Brighton Jones LLC boosted its stake in shares of Allstate by 60.2% in the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock worth $1,253,000 after acquiring an additional 2,443 shares during the period. Revolve Wealth Partners LLC bought a new position in shares of Allstate in the fourth quarter worth about $231,000. Bank of Nova Scotia boosted its stake in shares of Allstate by 1.0% in the second quarter. Bank of Nova Scotia now owns 29,575 shares of the insurance provider’s stock worth $5,954,000 after acquiring an additional 296 shares during the period. WINTON GROUP Ltd bought a new position in shares of Allstate in the second quarter worth about $210,000. Finally, BCS Private Wealth Management Inc. bought a new position in shares of Allstate in the second quarter worth about $332,000. Institutional investors own 76.47% of the company’s stock.

Allstate News Roundup

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Wells Fargo raised its price target to $229 and kept an “equal weight” rating, signaling modest upside versus recent levels and providing support for the stock. Wells Fargo price target raise
• Positive Sentiment: Zacks modestly increased its Q1 2026 and Q1 2028 EPS estimates (Q1 2026 to $6.65; Q1 2028 to $6.68), suggesting near-term earnings momentum in some quarters. Zacks estimate raises
• Positive Sentiment: Market commentary noted Allstate outperformed the broader market in the most recent session, which can attract short-term buying interest. Allstate rises higher than market
• Neutral Sentiment: Preview pieces are circulating ahead of Allstate’s next earnings report — useful context for expectations but not new company-specific data. Earnings preview
• Negative Sentiment: Zacks downgraded Allstate from “strong-buy” to “hold” and trimmed several quarterly EPS forecasts by a penny each (across Q2–Q4 2026 and parts of 2027). While cuts are immaterial in size, the rating change reduces buy-side momentum and can pressure sentiment. The Zacks consensus full-year EPS remains near $18.74. Zacks downgrades and cuts
• Negative Sentiment: A retaliation lawsuit alleging improper handling of a bias complaint was filed against Allstate — a reputational and potential legal risk; material financial impact is unclear but investors often view such suits as a negative catalyst. Retaliation suit

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.